The Children's Beverage Group, Inc. Settles Patent Royalty Issue

Business Wire, Nov 22, 1999

NORTHBROOK, Ill.--(BUSINESS WIRE)--Nov. 22, 1999--

The Children's Beverage Group, Inc. (OTC/BB: TCBG) announced today that In an effort to maximize shareholder value, The Children's Beverage Group, Inc has settled its royalty payment schedule under its twenty (20) year patent licensing agreement. The Children's Beverage Group Inc. will be obligated to pay the patent holder one (1) dollar per year unless there is a change of ownership.

Jon Darmstadter President & CEO of The Children's Beverage Group, Inc., stated "As the largest shareholder of The Children's Beverage Group, Inc., it has always been and will always be my intention to deliver the best return for all my shareholders. This is evidenced by our recent Rochester, NY Industrial Revenue Bond cash raise and now again on the patent licensing agreement."

The Children's Beverage Group unique "'rip it sip it'(TM) no spill pouch is currently manufactured for Wal-Mart(R) (NYSE: WMT) under the Great Value "BackPak" label. It is currently available at all Wal-Mart Supercenters and limited division one stores.

The Children's Beverage Group, Inc. is a unique beverage company directed at the billion dollar plus children's beverage market. The company's mission and goal has been to create cutting edge products using the latest in packaging technology. It features a patented no. 5,941,642 09/005,627, "Self-Contained Fluid Dispensing System" known in the trade as the 'rip it sip it'(TM) system. The company's products are being marketed by national retailers like Wal-Mart(R)(NYSE: WMT). The company has been featured on the nationally broadcast television program "Emerging Public Companies...the Story Behind the Symbol".

The statements contained in this release which are not historical facts contain forward-looking information with respect to plans, projections or future performance of the company: the occurrence of which involves certain risks and uncertainties that could cause the company's actual results to differ materially from expected results. Such risks include the timing of the implementation and the scope and success of the program described here.